can-modif
🇪🇺 TED
245264-2026
PADCEV 20 MG VIAL C/1 Principio activo: ENFORTUMAB
🌍 ES
Contenu du marché
Extrait automatiquementDescription
Suministro de medicamentos exclusivos Astellas Pharma S.A.
Valeur estimée
187 425,07 EUR
Date limite
10/04/2026
Région
Madrid (ES300)
Secteur
Antineoplastic and immunomodulating agents
Marchés similaires
Prior notice
08/05/2026
Managed Service for Endoscopy, Radiology, Cath Labs & CTC, and Theatres – Preliminary Market Engagement (Market Engagement Event)
GB
Prior notice
08/05/2026
Procurement of 1 No Navigational Robot-assisted Bronchoscopy platform
GB
J-145
Prior notice
08/05/2026
Supply of Independent Living Equipment
GB
Prior notice
08/05/2026
NHS National Framework for Tafamidis
GB